Catalent Partners with Spicona to Develop COVID-19 Vaccine Candidate Using GPEx® Cell Line Development Platform
Read the full press release from Catalent here. Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement…